Zealand Pharma
Clinical trials sponsored by Zealand Pharma, explained in plain language.
-
New drug could cut IV feeding days for bowel failure patients
Disease control Recruiting nowThis study tests a drug called glepaglutide in 90 adults with short bowel syndrome who need IV nutrition at least 3 days a week. The goal is to see if the drug can safely reduce the amount of IV support needed. Participants receive either the drug or a placebo twice weekly for se…
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
Healthy volunteers needed to test safety of experimental drug ZP9830
Knowledge-focused Recruiting nowThis study is the first time ZP9830 is being tested in humans. It aims to check the drug's safety and how the body processes it in 124 healthy adults aged 18-45. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and measure drug…
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC